1. Home
  2. KROS vs SBC Comparison

KROS vs SBC Comparison

Compare KROS & SBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • SBC
  • Stock Information
  • Founded
  • KROS 2015
  • SBC 2000
  • Country
  • KROS United States
  • SBC United States
  • Employees
  • KROS N/A
  • SBC N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • SBC
  • Sector
  • KROS Health Care
  • SBC
  • Exchange
  • KROS Nasdaq
  • SBC NYSE
  • Market Cap
  • KROS 589.8M
  • SBC 521.3M
  • IPO Year
  • KROS 2020
  • SBC N/A
  • Fundamental
  • Price
  • KROS $12.07
  • SBC $4.99
  • Analyst Decision
  • KROS Buy
  • SBC
  • Analyst Count
  • KROS 11
  • SBC 0
  • Target Price
  • KROS $45.33
  • SBC N/A
  • AVG Volume (30 Days)
  • KROS 2.0M
  • SBC 21.2K
  • Earning Date
  • KROS 02-26-2025
  • SBC 02-23-2025
  • Dividend Yield
  • KROS N/A
  • SBC N/A
  • EPS Growth
  • KROS N/A
  • SBC 737.76
  • EPS
  • KROS N/A
  • SBC 6.66
  • Revenue
  • KROS $651,000.00
  • SBC $223,344,699.00
  • Revenue This Year
  • KROS $303.27
  • SBC $14.23
  • Revenue Next Year
  • KROS N/A
  • SBC $16.70
  • P/E Ratio
  • KROS N/A
  • SBC $0.77
  • Revenue Growth
  • KROS 8037.50
  • SBC 28.24
  • 52 Week Low
  • KROS $9.78
  • SBC $4.95
  • 52 Week High
  • KROS $73.00
  • SBC $36.52
  • Technical
  • Relative Strength Index (RSI)
  • KROS 25.11
  • SBC N/A
  • Support Level
  • KROS $10.95
  • SBC N/A
  • Resistance Level
  • KROS $11.63
  • SBC N/A
  • Average True Range (ATR)
  • KROS 0.85
  • SBC 0.00
  • MACD
  • KROS 1.32
  • SBC 0.00
  • Stochastic Oscillator
  • KROS 32.89
  • SBC 0.00

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About SBC SBC MEDICAL GROUP HOLDINGS INCRPRTD

SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). They provide management services to a total of One hundred fifty eight franchisee treatment centers under the brand name Shonan Beauty Clinic located in Japan.

Share on Social Networks: